Sunzen Biotech Bhd Stock Earnings Per Share
| 0148 Stock | 0.32 0.01 3.23% |
Sunzen Biotech Bhd fundamentals help investors to digest information that contributes to Sunzen Biotech's financial success or failures. It also enables traders to predict the movement of Sunzen Stock. The fundamental analysis module provides a way to measure Sunzen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sunzen Biotech stock.
Sunzen |
Sunzen Biotech Bhd Company Earnings Per Share Analysis
Sunzen Biotech's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Sunzen Biotech Bhd has an Earnings Per Share of 0.0 times. This indicator is about the same for the Consumer Non-Cyclicals average (which is currently at 0.0) sector and about the same as Food & Tobacco (which currently averages 0.0) industry. This indicator is about the same for all Malaysia stocks average (which is currently at 0.0).
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Sunzen Fundamentals
| Return On Equity | 2.91 | |||
| Current Valuation | 128.73 M | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 1.34 X | |||
| Revenue | 90.48 M | |||
| EBITDA | 6.57 M | |||
| Net Income | 3.71 M | |||
| Total Debt | 5.08 M | |||
| Cash Flow From Operations | (16.36 M) | |||
| Market Capitalization | 147.73 M | |||
| Total Asset | 148.71 M | |||
| Z Score | 17.4 | |||
| Net Asset | 148.71 M |
About Sunzen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sunzen Biotech Bhd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sunzen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sunzen Biotech Bhd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sunzen Stock
Sunzen Biotech financial ratios help investors to determine whether Sunzen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sunzen with respect to the benefits of owning Sunzen Biotech security.